Histrine Levo 5mg tablets
Ferron Par Pharmaceuticals
Composition
Levocetirizine dihydrochloride | 5 mg |
Each Pack Contains
3 strips of 10 tablets
Dosage Form
![]() | tablet |
Dosage formTablet; coated
Flavor
None
W.H.O. Classification
R06A
Available In
![]() | Indonesia |
Warning

Alcohol
CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery
NOT RECOMMENDEDThis item should not be used while operating heavy machinery.

Pregnancy
NOT RECOMMENDEDThis item is not safe for use during pregnancy.

Lactation
NOT RECOMMENDEDThis item is not safe for use during lactation.
Indication
Levocetirizine is indicated for the treatment of symptoms associated with allergic conditions, such as:
Seasonal Allergic Rhinitis (including ocular symptoms)
Perennial Allergic Rhinitis
Chronic Idiopathic Urticaria
Seasonal Allergic Rhinitis (including ocular symptoms)
Perennial Allergic Rhinitis
Chronic Idiopathic Urticaria
Dosage
6 YEARS OLD AND ABOVE
The daily recommended dose is 5 mg (1 tablet)
UP TO 6 YEARS
No adjusted dosage is yet possible.
ELDERLY PATIENTS
Adjustment of the dose is recommended in elderly patients with moderate to severe renal impairment.
DURATION OF USE
The duration of use depends on the type, duration and course of the complaints. For hay fever 3-6 weeks, and in case of short-term pollen exposure as little as one week, is generally sufficient. For chronic urticaria and chronic allergic rhinitis, up to one year’s clinical experience is available for the racemate and up to 18 months in patients with pruritus associated with atopic dermatitis.
The daily recommended dose is 5 mg (1 tablet)
UP TO 6 YEARS
No adjusted dosage is yet possible.
ELDERLY PATIENTS
Adjustment of the dose is recommended in elderly patients with moderate to severe renal impairment.
DURATION OF USE
The duration of use depends on the type, duration and course of the complaints. For hay fever 3-6 weeks, and in case of short-term pollen exposure as little as one week, is generally sufficient. For chronic urticaria and chronic allergic rhinitis, up to one year’s clinical experience is available for the racemate and up to 18 months in patients with pruritus associated with atopic dermatitis.